Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta-analysis

被引:0
|
作者
Yinxue Guo
Pingyu Ge
Ziju Li
Jingxia Xiao
Lirui Xie
机构
[1] Guizhou University of Traditional Chinese Medicine,Department of Nephrology
[2] The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,Department of Urology
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:533 / 546
页数:13
相关论文
共 50 条
  • [31] Clopidogrel Versus Ticagrelor as Part of Dual-Antiplatelet Therapy for Patients With Acute Coronary Syndrome: A Meta-Analysis
    Myredal, Anna
    Bergh, Niklas
    Sjovall, Henrik
    Wallerstedt, Susanna
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B193 - B193
  • [32] Antiplatelet agents in cardiovascular disease
    Lopes, Renato D.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 306 - 309
  • [33] Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis
    Kamdar, Anna
    Sykes, Robert
    Morrow, Andrew
    Mangion, Kenneth
    Berry, Colin
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (04) : 1479 - 1490
  • [34] Antiplatelet agents in cardiovascular disease
    Renato D. Lopes
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 31 : 306 - 309
  • [35] Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis
    Balamuthusamy, Saravanan
    Srinivasan, Lavanya
    Verma, Meenakshi
    Adigopula, Sasikanth
    Jalandara, Nishant
    Hathiwala, Suresh
    Smith, Earl
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (05) : 791 - 805
  • [36] Comment on: "Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis"
    Rangwala, Hussain Sohail
    Fatima, Hareer
    Rangwala, Burhanuddin Sohail
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (03) : 465 - 466
  • [37] Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease A protocol of systematic review and meta-analysis
    Liu, Tongtong
    Guan, Yingjie
    Li, Juan
    Mao, Huimin
    Zhan, Yongli
    [J]. MEDICINE, 2020, 99 (47) : E23218
  • [38] Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
    Hussain Sohail Rangwala
    Hareer Fatima
    Burhanuddin Sohail Rangwala
    [J]. American Journal of Cardiovascular Drugs, 2024, 24 : 465 - 466
  • [39] Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease. A meta-analysis
    Hu, X.
    Shang, J.
    Yuan, W.
    Zhang, S.
    Jiang, Y.
    Zhao, B.
    Duan, Y.
    Xiao, J.
    Zhao, Z.
    [J]. HERZ, 2018, 43 (06) : 518 - 528
  • [40] Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis
    Dengpiao Xie
    Jianting Wang
    Xinping Wu
    Mingquan Li
    [J]. International Urology and Nephrology, 2018, 50 : 2201 - 2206